Trk receptor tyrosine kinases: a bridge between cancer and neural development.
暂无分享,去创建一个
[1] S. Pomeroy,et al. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Barbacid,et al. The trk family of tyrosine protein kinase receptors. , 1991, Biochimica et biophysica acta.
[3] W. Snider,et al. Functions of the neurotrophins during nervous system development: What the knockouts are teaching us , 1994, Cell.
[4] B. Hempstead,et al. TrkA Immunoglobulin-Like Ligand Binding Domains Inhibit Spontaneous Activation of the Receptor , 2000, Molecular and Cellular Biology.
[5] A. Nakagawara. Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. , 1998, Human cell.
[6] A. Cantor,et al. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. , 1993, The New England journal of medicine.
[7] T. Sladek,et al. Mediation of Nerve Growth Factor-driven Cell Cycle Arrest in PC12 Cells by p53 , 2000, The Journal of Biological Chemistry.
[8] U. Moll,et al. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] N. Seki,et al. Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFRα-1, and GFRα-2 , 1998 .
[10] L. Klesse,et al. Trks: Signal transduction and intracellular pathways , 1999, Microscopy research and technique.
[11] A. Nakagawara,et al. Expression of TrkC in favorable human neuroblastomas. , 1996, Oncogene.
[12] C. Pozniak,et al. P53 Is Essential for Developmental Neuron Death as Regulated by the TrkA and p75 Neurotrophin Receptors , 1998, The Journal of cell biology.
[13] S. Ménard,et al. Nerve Growth Factor Cooperates with p185 HER2 in Activating Growth of Human Breast Carcinoma Cells* , 2000, The Journal of Biological Chemistry.
[14] D. Stram,et al. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. , 1993, Journal of the National Cancer Institute.
[15] F. McCormick,et al. Opposing Effects of Ras on p53 Transcriptional Activation of mdm2 and Induction of p19ARF , 2000, Cell.
[16] M. Caligiuri,et al. Identification and Characterization of an Activating TrkA Deletion Mutation in Acute Myeloid Leukemia , 2022 .
[17] K. Matsumoto,et al. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. , 1995, Cancer research.
[18] A. Iavarone,et al. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins , 2000, Nature.
[19] G. Evan,et al. Cell Cycle Phase-Specific Surface Expression of Nerve Growth Factor Receptors TrkA and p75NTR , 1998, The Journal of Neuroscience.
[20] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[21] A. Nakagawara,et al. Expression and function of TRK-B and BDNF in human neuroblastomas , 1994, Molecular and cellular biology.
[22] R. Klein. Role of neurotrophins in mouse neuronal development , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] C. Thiele,et al. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells. , 1999, The American journal of pathology.
[24] J. Trojanowski,et al. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells , 2000, Oncogene.
[25] M. Barbacid,et al. The trk proto-oncogene encodes a receptor for nerve growth factor , 1991, Cell.
[26] M. Arima,et al. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. , 1992, Cancer research.
[27] J. Trojanowski,et al. A Novel Apoptotic Pathway Induced by Nerve Growth Factor-mediated TrkA Activation in Medulloblastoma* , 2000, The Journal of Biological Chemistry.
[28] K. Tanaka,et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). , 1999, Blood.
[29] R. Levi‐montalcini,et al. The nerve growth factor 35 years later. , 1987, Science.
[30] R. Birge,et al. Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor , 2000, Journal of neuroscience research.
[31] A. Nakagawara. Topical Topic: The NGF story and neuroblastoma , 1998 .
[32] G. Melino,et al. Induction of Neuronal Differentiation by p73 in a Neuroblastoma Cell Line* , 2000, The Journal of Biological Chemistry.
[33] S. Baylin,et al. Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[34] E. May,et al. Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis , 2000, Oncogene.
[35] A. Ross,et al. Gene transfer and molecular cloning of the human NGF receptor. , 1986, Science.
[36] D. Kaplan,et al. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor , 1991, Nature.
[37] F. McKeon,et al. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. , 2000, Science.
[38] F. McKeon,et al. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent , 1999, Oncogene.